Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective.
J Clin Virol
; 58(1): 67-73, 2013 Sep.
Article
em En
| MEDLINE
| ID: mdl-23880162
Palavras-chave
ADV; ALT; AST; ETV; Emtricitabine; FTC; GFR; HBIG; HBV; HBeAg; HBsAg; HCV; HDV; HIV; Hepatitis B; IU; Immunoglobulin; LAM; LAMr; Liver transplantation; MDRD; OLT; Prevention; TDF; TDF/FTC; Tenofovir; adefovir; alanine aminotransferase; anti-HBe; anti-HBs; aspartate aminotransferase; emtricitabine; entecavir; glomerular filtration rate; hepatitis B e antibody; hepatitis B e antigen; hepatitis B immunoglobulin; hepatitis B surface antibody; hepatitis B surface antigen; hepatitis B virus; hepatitis C virus; hepatitis delta virus; human immunodeficiency virus; international units; lamivudine; lamivudine resistance; modification of diet in renal disease; orthotopic liver transplantation; tenofovir; tenofovir and emtricitabine
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Antivirais
/
Adenina
/
Transplante de Fígado
/
Hepatite B Crônica
/
Desoxicitidina
/
Organofosfonatos
/
Anticorpos Anti-Hepatite B
Tipo de estudo:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article